safranal has been researched along with Hepatocellular Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Hrout, A; Alzahmi, A; Amin, A; Baig, B; Chaiboonchoe, A; El-Awady, R; Greish, YE; Khraiwesh, B; Murali, C; Nelson, DR; Ramadan, W; Salehi-Ashtiani, K; Tarazi, H | 1 |
1 other study(ies) available for safranal and Hepatocellular Carcinoma
Article | Year |
---|---|
Safranal induces DNA double-strand breakage and ER-stress-mediated cell death in hepatocellular carcinoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cyclohexenes; DNA Breaks, Double-Stranded; DNA Repair; Endoplasmic Reticulum Stress; G2 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Ontology; Gene Regulatory Networks; Hep G2 Cells; Humans; Liver Neoplasms; Terpenes | 2018 |